The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy (Q73141414)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2000

Language	Label	Description	Also known as
English	The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy	scientific article published on 01 November 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

author name string

A Yamamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Harada-Shiba

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Kawaguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Oi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kubo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Sakai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Mikami

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Imai

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Ito

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kato

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Endo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

I Sato

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Suzuki

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Hori

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

153

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

89-98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

How effective is drug therapy in heterozygous familial hypercholesterolemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Plasmapheresis for Prevention and Regression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Apheresis technology for prevention and regression of atherosclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Regression of carotid plaques during low density lipoprotein cholesterol elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Siblings with normal LDL receptor activity and severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Therapeutic effects of ML-236B in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Receptor-Mediated Control of Cholesterol Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Effects of probucol on homozygous cases of familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Identifiers

10.1016/S0021-9150(00)00373-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73141414&oldid=2222115390"